|
John Denney brings to Rapport his extensive institutional investment background and entrepreneurial expertise, having managed or funded multiple technology ventures. These companies include Raman Medical, which he founded and ran as CEO. Raman’s diagnostics technology was well-received in the biomedical community and was featured in multiple SBIR grants. Prior to Raman, Mr. Denney was brought in as President and CFO to turn around Boston Advanced Technologies, Inc., whose technology enabled non-destructive petrochemical testing via electro-optical instrumentation. In four years, he took the company from insolvent to a successful restart, selling it for seven times gross revenues and ultimately preserving investment capital from Boston University’s venture arm and others. As a founding member of RhumbLine Advisers in 1990, Mr. Denney grew their asset base from zero to $1.5 billion in five years. Mr. Denney holds a degree in Chemistry from the University of Massachusetts, is a Chartered Financial Analyst, and is active in the Association for Investment Management and Research. | 